A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients

Exclusion Criteria

• •1. Patients with autoimmune diseases, inflammation, or hematological disorders;
• •2. Patients with a history of or concurrent other cancers;
• •3. Presence of active infection and inflammation (based on WBC count, patients with count of 10×10\^9 or higher should be evaluated through medical record examination for the presence of infection);
• •4. Active bleeding (as determined by endoscopic ultrasound and HGB ≤ 90);
• •5. Post neoadjuvant radiotherapy or chemotherapy;
• •6. History of blood transfusion, corticosteroid use, or leukocyte-stimulating medications within the past month prior to blood draw;
• •7. Incomplete clinical and pathological data.